ELEVAI Labs Inc., is a California based medical aesthetic biotechnology company that has created and continues to invent innovative science driven efficacious topical skincare technologies for the medical dispense market. ELEVAI® has commercialized ELEVAI Exosomes™ a next generation, patent pending technology used in our ELEVAI® flagship products: ENFINITY™ and EMPOWER™ a patent pending regenerative skincare system for the post treatment market.
ELEVAI Exosomes ™ are generated by mesenchymal stem cells in our own GLP grade laboratories based in the US. ELEVAI Exosomes™ are handled only by trained US based scientists and tested for purity and quality before being used in our skincare formulations. Our exosomes are derived from pure, ethically sourced mesenchymal stem cells derived in a pharmaceutical grade cGMP lab environment.
The ELEVAI® skincare system is currently available in medical aesthetic offices across the US and Canada, with expected growth over 1200 accounts in 2023, plus ELEVAI® will soon to be available outside North America via our distribution partners.
The topical skincare industry is dominated by confusing, manipulative marketing claims and products with dated technology with limited or zero real scientific data of efficacy. At ELEVAI® we believe it doesn’t have to be this way and think consumers need better options and skincare products that has been created by real professional scientist, in a lab with properly researched biological technologies. This belief and passion is the genesis to our skincare technologies and has helped us shape start the transformation where skin beauty can be achieved for all ages.
We are revolutionizing the medical aesthetic skincare market with supercharged innovation, efficacious data driven skincare systems built on transparency and science.